P10275 ANDR_HUMAN

Gene name: AR
Protein name: Androgen receptor

List of molecules and drugs that target protein P10275
# DrugDomain Data DrugBank Accession Name Drug action Affinity data InChI Key SMILES
1 P10275_DB00255 DB00255 Diethylstilbestrol antagonist
RGLYKWWBQGJZGM-ISLYRVAYSA-N CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1
2 P10275_DB00367 DB00367 Levonorgestrel binder
WWYNJERNGUHSAO-XUDSTZEESA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
3 P10275_DB00396 DB00396 Progesterone agonist Ki(nM) = 8.5
IC50(nM) = 14.0
RJKFOVLPORLFTN-LEKSSAKUSA-N [H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
4 P10275_DB00421 DB00421 Spironolactone antagonist Ki(nM) = 39.4
IC50(nM) = 48.0
EC50(nM) = 20000.0
LXMSZDCAJNLERA-ZHYRCANASA-N [H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O
5 P10275_DB00499 DB00499 Flutamide antagonist Ki(nM) = 1300.0
IC50(nM) = 154.0
MKXKFYHWDHIYRV-UHFFFAOYSA-N CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
6 P10275_DB00621 DB00621 Oxandrolone agonist
QSLJIVKCVHQPLV-PEMPUTJUSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C
7 P10275_DB00623 DB00623 Fluphenazine n/a
PLDUPXSUYLZYBN-UHFFFAOYSA-N OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
8 P10275_DB00624 DB00624 Testosterone agonist Ki(nM) = 3.2
IC50(nM) = 2.7
Kd(nM) = 0.4
EC50(nM) = 1.1
MUMGGOZAMZWBJJ-DYKIIFRCSA-N [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
9 P10275_DB00648 DB00648 Mitotane antagonist
JWBOIMRXGHLCPP-UHFFFAOYSA-N ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=CC=CC=C1Cl
10 P10275_DB00655 DB00655 Estrone n/a
DNXHEGUUPJUMQT-CBZIJGRNSA-N [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3
11 P10275_DB00665 DB00665 Nilutamide antagonist IC50(nM) = 9.0
XWXYUMMDTVBTOU-UHFFFAOYSA-N CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
12 P10275_DB00675 DB00675 Tamoxifen n/a
NKANXQFJJICGDU-QPLCGJKRSA-N CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1
13 P10275_DB00717 DB00717 Norethisterone agonist
VIKNJXKGJWUCNN-XGXHKTLJSA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
14 P10275_DB00858 DB00858 Drostanolone agonist
IKXILDNPCZPPRV-RFMGOVQKSA-N [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C
15 P10275_DB00957 DB00957 Norgestimate partial agonist
KIQQMECNKUGGKA-NMYWJIRASA-N [H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O
16 P10275_DB00984 DB00984 Nandrolone phenpropionate agonist
UBWXUGDQUBIEIZ-QNTYDACNSA-N [H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
17 P10275_DB01026 DB01026 Ketoconazole binder
XMAYWYJOQHXEEK-UHFFFAOYSA-N CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
18 P10275_DB01063 DB01063 Acetophenazine n/a
WNTYBHLDCKXEOT-UHFFFAOYSA-N CC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1
19 P10275_DB01128 DB01128 Bicalutamide antagonist Ki(nM) = 11.0
IC50(nM) = 10.0
EC50(nM) = 157.0
LKJPYSCBVHEWIU-UHFFFAOYSA-N CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
20 P10275_DB01185 DB01185 Fluoxymesterone agonist Ki(nM) = 5.7
EC50(nM) = 0.3
YLRFCQOZQXIBAB-RBZZARIASA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C
21 P10275_DB01395 DB01395 Drospirenone antagonist IC50(nM) = 27.0
METQSPRSQINEEU-HXCATZOESA-N [H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21
22 P10275_DB01406 DB01406 Danazol agonist
POZRVZJJTULAOH-LHZXLZLDSA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3
23 P10275_DB01420 DB01420 Testosterone propionate agonist Ki(nM) = 0.25
PDMMFKSKQVNJMI-BLQWBTBKSA-N [H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
24 P10275_DB01428 DB01428 Oxybenzone antagonist
DXGLGDHPHMLXJC-UHFFFAOYSA-N COC1=CC(O)=C(C=C1)C(=O)C1=CC=CC=C1
25 P10275_DB01481 DB01481 1-Testosterone agonist
OKJCFMUGMSVJBG-ABEVXSGRSA-N [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C=C[C@]12C
26 P10275_DB01541 DB01541 Boldenone agonist
RSIHSRDYCUFFLA-DYKIIFRCSA-N [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
27 P10275_DB01564 DB01564 Calusterone n/a
IVFYLRMMHVYGJH-PVPPCFLZSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](C)CC2=CC(=O)CC[C@]12C
28 P10275_DB01608 DB01608 Periciazine n/a
LUALIOATIOESLM-UHFFFAOYSA-N OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1
29 P10275_DB01708 DB01708 Prasterone agonist
FMGSKLZLMKYGDP-USOAJAOKSA-N [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
30 P10275_DB02266 DB02266 Flufenamic acid n/a IC50(nM) = 50000.0
EC50(nM) = 67000.0
LPEPZBJOKDYZAD-UHFFFAOYSA-N OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F
31 P10275_DB02901 DB02901 Stanolone n/a
NVKAWKQGWWIWPM-ABEVXSGRSA-N [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
32 P10275_DB02932 DB02932 (R)-Bicalutamide n/a Ki(nM) = 11.0
IC50(nM) = 120.23
LKJPYSCBVHEWIU-KRWDZBQOSA-N C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
33 P10275_DB02998 DB02998 Metribolone activator Ki(nM) = 0.4
IC50(nM) = 0.302
Kd(nM) = 0.52
EC50(nM) = 0.013
CCCIJQPRIXGQOE-XWSJACJDSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
34 P10275_DB04709 DB04709 (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE n/a
DEJXHCDDTLTVNB-FRVJLOGJSA-N [H][C@]12C(=O)N(C(=O)[C@@]1([H])[C@]1([H])CC[C@@]2([H])CC1)C1=CC=C(C2=CC=CC=C12)[N+]([O-])=O
35 P10275_DB04839 DB04839 Cyproterone acetate antagonist Ki(nM) = 14.0
IC50(nM) = 23.0
UWFYSQMTEOIJJG-FDTZYFLXSA-N [H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@]12[H]
36 P10275_DB05234 DB05234 LGD2941 n/a Ki(nM) = 1.5
EC50(nM) = 7.1
HWLLYFXDDGGHOE-BCSUUIJWSA-N C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1
37 P10275_DB06133 DB06133 Dimethylcurcumin inhibitor
ZMGUKFHHNQMKJI-CIOHCNBKSA-N COC1=CC=C(\C=C\C(\O)=C\C(=O)\C=C\C2=CC(OC)=C(OC)C=C2)C=C1OC
38 P10275_DB06412 DB06412 Oxymetholone agonist
ICMWWNHDUZJFDW-DHODBPELSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O
39 P10275_DB06710 DB06710 Methyltestosterone agonist
GCKMFJBGXUYNAG-HLXURNFRSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
40 P10275_DB06713 DB06713 Norelgestromin partial agonist
ISHXLNHNDMZNMC-XUDSTZEESA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
41 P10275_DB06718 DB06718 Stanozolol agonist
LKAJKIOFIWVMDJ-IYRCEVNGSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C
42 P10275_DB06870 DB06870 Tetrahydrogestrinone n/a
OXHNQTSIKGHVBH-ANULTFPQSA-N [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
43 P10275_DB07039 DB07039 (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide n/a
RXSZCFAPSDTELY-SFHVURJKSA-N C[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(I)=C1
44 P10275_DB07286 DB07286 BMS-564929 n/a
KEJORAMIZFOODM-PWSUYJOCSA-N [H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=C(C)C(Cl)=C(C=C1)C#N
45 P10275_DB07419 DB07419 S-23 n/a Ki(nM) = 1.7
SSFVOEAXHZGTRJ-KRWDZBQOSA-N C[C@](O)(COC1=CC=C(Cl)C(F)=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F
46 P10275_DB07421 DB07421 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile n/a
INVUBEGZQHQAMY-SJORKVTESA-N [H][C@](O)(NC1=CC(=C(C=C1)C#N)C(F)(F)F)[C@@](C)(O)COC1=CC=C(C=C1)[N+]([O-])=O
47 P10275_DB07422 DB07422 (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide n/a
MMNRWNREMUMYQG-INIZCTEOSA-N C[C@](O)(COC1=C(F)C(F)=C(F)C(F)=C1F)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O
48 P10275_DB07423 DB07423 Andarine n/a Ki(nM) = 4.0
YVXVTLGIDOACBJ-SFHVURJKSA-N CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC=C(C(=C2)C(F)(F)F)[N+]([O-])=O)C=C1
49 P10275_DB07454 DB07454 (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE n/a Ki(nM) = 0.3
QDSWNDMHSBZXKX-JTQLQIEISA-N C[C@](O)(CBr)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
50 P10275_DB07717 DB07717 (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE n/a
AJODXHGZHBERGJ-JLYQOUBASA-N [H][C@]1(O)CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])CC(=O)CC[C@]4(C)[C@@]3([H])CC[C@]12CCOCC1=CC(F)=CC(F)=C1
51 P10275_DB07769 DB07769 S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE n/a Ki(nM) = 6.1
KJMFOTCDISOHDX-INIZCTEOSA-N C[C@](O)(COC1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
52 P10275_DB08035 DB08035 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE n/a
QUPXEJURIFFVSX-UHFFFAOYSA-N CC1=CC=C(C)C(CC2=NN(C3=C2C(N)=NC=N3)C(C)(C)C)=C1
53 P10275_DB08087 DB08087 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE n/a
NHBIWLQQJPSMNP-CABCVRRESA-N [H][C@@]1(O)CCN2C(=O)N(C(=O)[C@]12[H])C1=CC=C(C#N)C2=CC=CC=C12
54 P10275_DB08088 DB08088 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile n/a Ki(nM) = 0.3
EC50(nM) = 0.2
KALFKWQLCWAXJO-RNSKTZJQSA-N N#CC1=CC=C(\N=C2/O[C@@]([H])(C(F)(F)F)[C@]3([H])[C@](O)([H])CCN23)C(C)=C1Cl
55 P10275_DB08089 DB08089 LGD-2226 n/a Ki(nM) = 1.0
EC50(nM) = 0.2
ULBPQWIGZUGPHU-UHFFFAOYSA-N FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1
56 P10275_DB08461 DB08461 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL n/a
QMAIQPBRCNEJAT-UHFFFAOYSA-N CC(C)(C)N1N=C(CC2=CC(O)=CC=C2)C2=C1N=CN=C2N
57 P10275_DB08604 DB08604 Triclosan n/a
XEFQLINVKFYRCS-UHFFFAOYSA-N OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1
58 P10275_DB08804 DB08804 Nandrolone decanoate agonist
JKWKMORAXJQQSR-MOPIKTETSA-N [H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
59 P10275_DB08867 DB08867 Ulipristal n/a
HKDLNTKNLJPAIY-WKWWZUSTSA-N CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12
60 P10275_DB08899 DB08899 Enzalutamide inhibitor Ki(nM) = 17.0
IC50(nM) = 14.0
Kd(nM) = 6520.0
EC50(nM) = 49.0
WXCXUHSOUPDCQV-UHFFFAOYSA-N CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F
61 P10275_DB09086 DB09086 Eugenol antagonist IC50(nM) = 19000.0
RRAFCDWBNXTKKO-UHFFFAOYSA-N COC1=C(O)C=CC(CC=C)=C1
62 P10275_DB09123 DB09123 Dienogest antagonist
AZFLJNIPTRTECV-FUMNGEBKSA-N [H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H]
63 P10275_DB09371 DB09371 Norethynodrel n/a
ICTXHFFSOAJUMG-SLHNCBLASA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3
64 P10275_DB09389 DB09389 Norgestrel agonist
WWYNJERNGUHSAO-UHFFFAOYSA-N CCC12CCC3C(CCC4=CC(=O)CCC34)C1CCC2(O)C#C
65 P10275_DB11064 DB11064 Homosalate antagonist
WSSJONWNBBTCMG-UHFFFAOYSA-N CC1CC(CC(C)(C)C1)OC(=O)C1=C(O)C=CC=C1
66 P10275_DB11219 DB11219 Enzacamene antagonist
HEOCBCNFKCOKBX-SDNWHVSQSA-N CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1
67 P10275_DB11425 DB11425 Luprostiol inhibitor
KFUDFIMHDRJVLV-OZCLATTGSA-N O[C@H](COC1=CC(Cl)=CC=C1)CS[C@@H]1[C@@H](O)C[C@@H](O)[C@H]1C\C=C/CCCC(O)=O
68 P10275_DB11429 DB11429 Mibolerone n/a
PTQMMNYJKCSPET-OMHQDGTGSA-N [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3C[C@@H](C)[C@@]21[H]
69 P10275_DB11447 DB11447 Phenothiazine n/a
WJFKNYWRSNBZNX-UHFFFAOYSA-N N1C2=CC=CC=C2SC2=CC=CC=C12
70 P10275_DB11619 DB11619 Gestrinone antagonist
BJJXHLWLUDYTGC-ANULTFPQSA-N [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H]
71 P10275_DB11901 DB11901 Apalutamide antagonist
HJBWBFZLDZWPHF-UHFFFAOYSA-N CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
72 P10275_DB12499 DB12499 Clascoterone antagonist
GPNHMOZDMYNCPO-PDUMRIMRSA-N [H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
73 P10275_DB12941 DB12941 Darolutamide antagonist
BLIJXOOIHRSQRB-PXYINDEMSA-N C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O
74 P10275_DB13155 DB13155 Esculin agonist
XHCADAYNFIFUHF-TVKJYDDYSA-N OC[C@H]1O[C@@H](OC2=C(O)C=C3OC(=O)C=CC3=C2)[C@H](O)[C@@H](O)[C@@H]1O
75 P10275_DB13934 DB13934 Ligandrol antagonist
OPSIVAKKLQRWKC-VXGBXAGGSA-N O[C@H]([C@H]1CCCN1C1=CC=C(C#N)C(=C1)C(F)(F)F)C(F)(F)F
76 P10275_DB13943 DB13943 Testosterone cypionate agonist
HPFVBGJFAYZEBE-ZLQWOROUSA-N [H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
77 P10275_DB13944 DB13944 Testosterone enanthate agonist
VOCBWIIFXDYGNZ-IXKNJLPQSA-N [H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
78 P10275_DB13946 DB13946 Testosterone undecanoate agonist
UDSFVOAUHKGBEK-CNQKSJKFSA-N CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
79 P10275_DB13951 DB13951 Stanolone acetate n/a
ILCTUFVQFCIIDS-NGFSFWIMSA-N [H][C@@]12CC[C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
80 P10275_DB14583 DB14583 Segesterone acetate agonist
CKFBRGLGTWAVLG-GOMYTPFNSA-N [H][C@@]12CC(=C)[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]
81 P10275_DB14639 DB14639 Boldenone undecylenate n/a
AHMMSNQYOPMLSX-CNQKSJKFSA-N C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C
82 P10275_DB15488 DB15488 Echinacoside agonist
FSBUXLDOLNLABB-ISAKITKMSA-N C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)\C=C\C2=CC(O)=C(O)C=C2)[C@H](O)[C@H](O)[C@H]1O
83 P10275_DB15647 DB15647 Ketodarolutamide antagonist
GMBPVBVTPBWIKC-NSHDSACASA-N C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)=O